[Hairy cell leukemia: Part II: therapy with cladribine]

Author(s): Barth J, Rummel MJ

Affiliation(s): Medizinische Klinik und Poliklinik IV des Universitatsklinikums Giessen, Klinikstrasse 36, 35385 Giessen. Juergen.Barth@innere.med.uni-giessen.de

Publication date & source: 2009-07, Med Monatsschr Pharm., 32(7):252-60.

Publication type: English Abstract; Review

The purine analogue cladribine is a highly active cytotoxic drug for the treatment of hairy cell leukemia. The substance is easy to use and patient friendly. After preparation of a special, sophisticated formulation by a pharmaceutical cytotoxic lab, the patient might even apply the drug himself. This review points out the potential of this non-patented pharmaceutical, besides practical advices.